International Meeting on Pharmacovigilance in Psychiatry, Therapeutic Drug Monitoring and Pharmacogenetics of Psychotropic Drugs

Aamo, T.

Developing Functional Routines for TDM and Pharmacogenetics Tests in Psychiatry

Aamo, T. O.

Developing Functional Routines for TDM and Pharmacogenetic Tests in Psychiatry

Abumaria, N.

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Abu-Tair, F.

Increase in Plasma Concentrations of Amisulpride after Receiving Co-Medication with Lithium

Valproate Lowers Plasma Concentrations of Olanzapine

Ackenheil, M.

No Change of Amitriptyline Concentration by Comedication of Tranylcypromine

Adami, P.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Aderjan, R.

Forensic Analysis and Therapeutic Monitoring of Psychotropic Drugs

Ahlner, J.

Forensic Toxicology in a Broader Perspective – With Special Reference to Psychotropic Drugs

Albertsen, U.

Therapeutic Drug Monitoring of Paroxetine in a Naturalistic Clinical Setting

Aldenhoff, J.

Editorial

Appelberg, B.

Clozapine induced QEEG Changes Correlate with Clinical Response in Schizophrenic Patients – A Prospective, Longitudinal Study

Arneth, B.

Rapid and Reliable Genotyping Procedure for Detection of Alleles with Mutation, Deletion or/and Duplication of the CYP2D6-Gene

Arranz, M. J.

Genetics and the Pharmacokinetics and Pharmacodynamics of Psychiatric Drugs

Aubry, J. M.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Bader, W.

Determination of Five Commonly Used Antipsychotics in Human Serum by High Performance-Liquid Chromatography (HPLC) and Electrochemical Detection

Bate, A.

Principles of Signal Detection and Data Mining and their Application to Psychotropic Drugs

Baud, P.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Baumann, P.

Plasma-CSF Concentrations Relationship of Psychotropic Drugs

Editorial

Clinical Relevance of Citalopram (CIT) Plasma and Cerebrospinal Fluid (CSF) Concentrations: Impact with CSF Monoamine Metabolites

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

TDM and Pharmacogenetic Tests as Tools in Pharmacovigilance: Case Reports

Follow-Up of a Pharmacovigilance Study in Psychiatry Involving TDM and Pharmacogenetic Testing

Severe Bruising as an Adverse Event: Chocolate or Fluvoxamine? Case Report

High Sedation with Low Doses of Atypical Antipsychotics in 3 Young Patients (13 to 14 Years Old)

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Will Genotyping and Phenotyping Methods Replace TDM in the Future?

Bellivier, F.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Bender, S.

AMSP Methods and Results on Severe ADR due to Antipsychotics

Bengtsson, F.

Ziprasidone and Methyldihydroziprasidone Kinetics as Displayed in the Naturalistic Clinical Setting by Applying a TDM-Routine

Pharmacokinetic Variance of Mirtazapine and N-Demethylmirtazapine in Patients Treated for Major Depressive Disorder: A Six Months Therapeutic Drug Monitoring Study

Therapeutic Drug Monitoring of Paroxetine in a Naturalistic Clinical Setting

Motives for investing in TDM and Pharmacogenetic Tests when Treating Patients at Risk

Bergemann, N.

Increase in Plasma Concentrations of Amisulpride after Receiving Co-Medication with Lithium

Valproate Lowers Plasma Concentrations of Olanzapine

Berney, P.

What Is the Evidence for Systematic Monitoring of Tricyclic Antidepressant Concentrations?

Nefazodone Withdrawal Syndrome Responds to the Administration of Trazodone

Betzl, F.

Risperidone Plasma Levels in the Elderly with Dementia

Bisdas, S.

Therapeutic Drug Monitoring of Antidepressants and Length of Stay of Psychiatric Inpatients

Bohman, L.

Experience with CYP2D6 Genotyping in Psychiatry

Bondy, B.

Pharmacodynamic and Pharmacogenetics: Focus on Adverse Effects

Boucherie, M.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Brunnauer, A.

Risperidone Plasma Levels in the Elderly with Dementia

Brøsen, K.

The Role of Pharmacogenetics/-Genomics in the Pharmacovigilance of Neuro-/Psychotropic Drugs

Buclin, T.

Pharmacovigilance en Psychiatrie

Transport Proteins Regulating Drug Uptake in Brain

Buresi, C.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Burger, R.

Therapeutic Drug Monitoring in a Naturalistic Clinical Setting

Caputi, A. P.

Neuropsychiatric Adverse Drug Reactions in General Practice

Casagrande Tango, R.

What Is the Evidence for Systematic Monitoring of Tricyclic Antidepressant Concentrations?

Cherma, M.

Ziprasidone and Methyldihydroziprasidone Kinetics as Displayed in the Naturalistic Clinical Setting by Applying a TDM-Routine

Christensen, E. B.

Pharmacogenetics initiatives from an industrial Perspective

Christians, U.

Automated Analysis of Antipsychotic Drugs Using Liquid Chromatography with Column Switching

Conca, A.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Czermak, C.

The Dopaminergic System, its Role in the Pathophysiology of Psychosis and Schizophrenia and Treatment by Atypical Antipsychotics

Dahmen, N.

Genetic Polymorphisms and Antipsychotic Medication: Short Term and Long Term Effects

Weight Gain in the AMSP System

Danielowski, K.

Therapeutic Drug Monitoring of Antidepressants and Length of Stay of Psychiatric Inpatients

Daum-Kreysch, E.

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

Dayer-Daeniker, I.

Nefazodone Withdrawal Syndrome Responds to the Administration of Trazodone

Degner, D.

Plasma Prolactin Levels During Treatment with Olanzapine

De Vries, C. S.

Antidepressant Utilisation and Suicide Attempts in Children and Adolescents

GP Databases, Record Linkage

Distler, G.

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

Dragicevic, A.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Serum Concentrations of Quetiapine and Clinical Effects

Eap, C. B.

Plasma-CSF Concentrations Relationship of Psychotropic Drugs

TDM and Pharmacogenetic Tests as Tools in Pharmacovigilance: Case Reports

Follow-Up of a Pharmacovigilance Study in Psychiatry Involving TDM and Pharmacogenetic Testing

High Sedation with Low Doses of Atypical Antipsychotics in 3 Young Patients (13 to 14 Years Old)

Will Genotyping and Phenotyping Methods Replace TDM in the Future?

Eberl, J.

Risperidone Plasma Levels in the Elderly with Dementia

Eckermann, G.

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Egger, C.

Electrolyte Disturbances Due to Dual Antidepressants

Eliasson, E.

Experience with CYP2D6 Genotyping in Psychiatry

Engel, R.

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

AMSP Methods and Results on Severe ADR due to Antipsychotics

Eschalier, A.

Pharmacovigilance in France: Recent Data on Psychotropic Drugs an Causality Assessment

Espnes, K. A.

Developing Functional Routines for TDM and Pharmacogenetic Tests in Psychiatry

Ettore Giustini, S.

Neuropsychiatric Adverse Drug Reactions in General Practice

Fattinger, K.

Epidemiology of Adverse Drug Reactions

Ferrero, F.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Finzel, M.

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

Fluegge, G.

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Fric, M.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

Risperidone Plasma Levels in the Elderly with Dementia

Frick, A.

Increase in Plasma Concentrations of Amisulpride after Receiving Co-Medication with Lithium

Valproate Lowers Plasma Concentrations of Olanzapine

Gaertner, I.

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Galatti, L.

Neuropsychiatric Adverse Drug Reactions in General Practice

Geiger, E.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Genz, A.

Haloperidol Pyridinium Serum Levels and Tardive Dyskinesia

Gerlach, M.

Therapeutic Drug Monitoring of Quetiapine in Child and Adolescents

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Giegling, I.

Genetic Polymorphisms and Antipsychotic Medication: Short Term and Long Term Effects

Goepfert, C.

Valproate-induced Encephalopathy: A Depiction of Symptoms on the Basis of a Case Report

A First Report of Psychosis with Voriconazole in a Patient with AML and Bronchitis

Göhring, J.

Pharmacovigilance of Jatrosom N (Tranylcypromine): Preliminary Data of a Post-Authorisation Surveillance Study

Grasmäder, K.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Greiner, C.

Determination of Citalopram and its Main Metabolite Desmethylcitalopram in Human Serum by Column-Switching High Performance-Liquid Chromatography (HPLC) and Spectrophotometric Detection

Grohmann, R.

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

Psychotropic Drug Use in Psychiatric Inpatients: Recent Trends in Dosage and Choice of Psychotropic Drug in 3 German Speaking Countries

AMSP Methods and Results on Severe ADR due to Antipsychotics

Gross, A.

Clozapine induced QEEG Changes Correlate with Clinical Response in Schizophrenic Patients – A Prospective, Longitudinal Study

Groß, M.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Haen, E.

Determination of Five Commonly Used Antipsychotics in Human Serum by High Performance-Liquid Chromatography (HPLC) and Electrochemical Detection

Relevance of Clinical Pharmacological Comments in TDM

Valproate-induced Encephalopathy: A Depiction of Symptoms on the Basis of a Case Report

A First Report of Psychosis with Voriconazole in a Patient with AML and Bronchitis

Determination of Citalopram and its Main Metabolite Desmethylcitalopram in Human Serum by Column-Switching High Performance-Liquid Chromatography (HPLC) and Spectrophotometric Detection

Haeri, J.

Weight Gain in the AMSP System

Haertter, S.

Rapid and Reliable Genotyping Procedure for Detection of Alleles with Mutation, Deletion or/and Duplication of the CYP2D6-Gene

Halfon, O.

High Sedation with Low Doses of Atypical Antipsychotics in 3 Young Patients (13 to 14 Years Old)

Hartmann, K.

Industry Databases

Härtter, S.

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

Serum Concentrations of Quetiapine and Clinical Effects

Hausmann, A.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Havemann-Reinecke, U.

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Heller, S.

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

Hendset, M.

Therapeutic Drug Monitoring in Psychiatry: Experience from Norway

Individual and Dose-Dependent Variability in R- and S-Mirtazapine Ratio Among Patients Treated with Racemic Mirtazapine

Herbold, M.

Forensic Analysis and Therapeutic Monitoring of Psychotropic Drugs

Hiemke, C.

Rapid and Reliable Genotyping Procedure for Detection of Alleles with Mutation, Deletion or/and Duplication of the CYP2D6-Gene

Automated Analysis of Antipsychotic Drugs Using Liquid Chromatography with Column Switching

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Therapeutic Drug Monitoring of Antidepressants and Length of Stay of Psychiatric Inpatients

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Determination of Citalopram and its Main Metabolite Desmethylcitalopram in Human Serum by Column-Switching High Performance-Liquid Chromatography (HPLC) and Spectrophotometric Detection

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Serum Concentrations of Quetiapine and Clinical Effects

Hinterhuber, H.

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

Hippius, H.

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

Höfgen, B.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Holmgren, P.

Forensic Toxicology in a Broader Perspective – With Special Reference to Psychotropic Drugs

Holzer, L.

High Sedation with Low Doses of Atypical Antipsychotics in 3 Young Patients (13 to 14 Years Old)

Hornung, J. P.

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

Horvath, A.

Psychotropic Drug Use in Psychiatric Inpatients: Recent Trends in Dosage and Choice of Psychotropic Drug in 3 German Speaking Countries

AMSP Data on Antidepressants and Suicidality

Ignjatovic, D.

Pharmacological Treatment of Late-Life Depression

Ignjatovic, M.

Comparison of Galantamine and Rivastigmin Effects –12-Month Study

Pharmacological Treatment of Late-Life Depression

Ignjatovièová, D.

Comparison of Galantamine and Rivastigmin Effects –12-Month Study

Jaquenoud Sirot, E.

TDM and Pharmacogenetic Tests as Tools in Pharmacovigilance: Case Reports

Follow-Up of a Pharmacovigilance Study in Psychiatry Involving TDM and Pharmacogenetic Testing

Severe Bruising as an Adverse Event: Chocolate or Fluvoxamine? Case Report

Pharmacovigilance en Psychiatrie

Jonzier-Perey, M.

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

Joutsiniemi, S. L.

Clozapine induced QEEG Changes Correlate with Clinical Response in Schizophrenic Patients – A Prospective, Longitudinal Study

Kasper, S.

Psychotropic Drug Use in Psychiatric Inpatients: Recent Trends in Dosage and Choice of Psychotropic Drug in 3 German Speaking Countries

Kerwin, R. W.

Genetics and the Pharmacokinetics and Pharmacodynamics of Psychiatric Drugs

Kirchheiner, J.

Genotype Specific Dosages of Antidepressants – A Proposal

Kirchherr, H.

A Simple and Sensitive Method for the Determination of Tranylcypromine in Plasma with LC-MS/MS

Kirchmeier, T.

Risperidone Plasma Levels in the Elderly with Dementia

Knezevic, B.

TDM and Pharmacogenetic Tests as Tools in Pharmacovigilance: Case Reports

König, P.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Rare Combinations of Ssris in Cotherapy with Other Antidepressants: The Importance of TDM

Konstantinidis, A.

Psychotropic Drug Use in Psychiatric Inpatients: Recent Trends in Dosage and Choice of Psychotropic Drug in 3 German Speaking Countries

Kopitz, J.

Increase in Plasma Concentrations of Amisulpride after Receiving Co-Medication with Lithium

Valproate Lowers Plasma Concentrations of Olanzapine

Kramer-Reinstadler, K.

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

Kress, K. R.

Increase in Plasma Concentrations of Amisulpride after Receiving Co-Medication with Lithium

Valproate Lowers Plasma Concentrations of Olanzapine

Kropp, S.

Galactorrhea and Antipsychotic Use: Data from the AMSP

Plasma Prolactin Levels During Treatment with Olanzapine

Kühn-Velten, W. N.

A Simple and Sensitive Method for the Determination of Tranylcypromine in Plasma with LC-MS/MS

Kuss, H. J.

Analytical Issues Regarding Psychotropic Agents and Weighted Regression for Data Interpretation

No Change of Amitriptyline Concentration by Comedication of Tranylcypromine

The German Network on Depression: TDM of New and Old Antidepressant Drugs

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Lackner, K.

Rapid and Reliable Genotyping Procedure for Detection of Alleles with Mutation, Deletion or/and Duplication of the CYP2D6-Gene

Laux, G.

Workshop: Psychotropic Drugs and Driver Impairment

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Mirtazapine Plasma Levels: Application of a Modified Target Concentration Intervention (TCI)

Risperidone Plasma Levels in the Elderly with Dementia

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Leboyer, M.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Lechner, T.

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

Lepore, M.

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

Lunder, N.

Individual and Dose-Dependent Variability in R- and S-Mirtazapine Ratio Among Patients Treated with Racemic Mirtazapine

Maier, W.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Malafosse, A.

Antidepressant-induced Mania, Rapid Cycling and the Serotonin Transporter Gene Polymorphism

Mancama, D.

Genetics and the Pharmacokinetics and Pharmacodynamics of Psychiatric Drugs

Mann, K.

Therapeutic Drug Monitoring of Antidepressants and Length of Stay of Psychiatric Inpatients

Mathé, A. A.

Clinical Relevance of Citalopram (CIT) Plasma and Cerebrospinal Fluid (CSF) Concentrations: Impact with CSF Monoamine Metabolites

Mehler-Wex, C.

Therapeutic Drug Monitoring of Quetiapine in Child and Adolescents

Melchner, D.

Determination of Five Commonly Used Antipsychotics in Human Serum by High Performance-Liquid Chromatography (HPLC) and Electrochemical Detection

Determination of Citalopram and its Main Metabolite Desmethylcitalopram in Human Serum by Column-Switching High Performance-Liquid Chromatography (HPLC) and Spectrophotometric Detection

Möller, H. J.

Risperidone Plasma Levels, Clinical Response and Side-Effects

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

Moore, N.

Examples of Use of Psychopharmacoepidemiology

General Introduction ISOP

Müller, M. J.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Serum Concentrations of Quetiapine and Clinical Effects

Müller, N.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Müller-Arends, A.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Müller-Oerlinghausen, B.

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Nesvåg, R.

Therapeutic Drug Monitoring of Patients on Risperidone Depot

Niedmann, P.

Plasma Prolactin Levels During Treatment with Olanzapine

Nikisch, G.

Plasma-CSF Concentrations Relationship of Psychotropic Drugs

Clinical Relevance of Citalopram (CIT) Plasma and Cerebrospinal Fluid (CSF) Concentrations: Impact with CSF Monoamine Metabolites

Nonenmacher, T.

Determination of Five Commonly Used Antipsychotics in Human Serum by High Performance-Liquid Chromatography (HPLC) and Electrochemical Detection

Nutt, D. J.

Pharmacological Treatment of Late-Life Depression

Ostermeier, C. P.

Valproate-induced Encephalopathy: A Depiction of Symptoms on the Basis of a Case Report

Paschoud, A.

Nefazodone Withdrawal Syndrome Responds to the Administration of Trazodone

Paus, E.

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

Pawelzik, M.

Pharmacovigilance of Jatrosom N (Tranylcypromine): Preliminary Data of a Post-Authorisation Surveillance Study

Pfuhlmann, B.

Therapeutic Drug Monitoring in a Naturalistic Clinical Setting

Polak, T.

Therapeutic Drug Monitoring in a Naturalistic Clinical Setting

Polimeni, G.

Neuropsychiatric Adverse Drug Reactions in General Practice

Prapotnik, M.

Rare Combinations of Ssris in Cotherapy with Other Antidepressants: The Importance of TDM

Prochazka, J.

Pharmacokinetic Variance of Mirtazapine and N-Demethylmirtazapine in Patients Treated for Major Depressive Disorder: A Six Months Therapeutic Drug Monitoring Study

Rao, M. L.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Risperidone Plasma Levels in the Elderly with Dementia

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Refsum, H.

Therapeutic Drug Monitoring in Psychiatry: Experience from Norway

Individual and Dose-Dependent Variability in R- and S-Mirtazapine Ratio Among Patients Treated with Racemic Mirtazapine

Reis, M.

Pharmacokinetic Variance of Mirtazapine and N-Demethylmirtazapine in Patients Treated for Major Depressive Disorder: A Six Months Therapeutic Drug Monitoring Study

Renger, H.

Dopamine-Mediated Adverse Drug Reactions Caused by Atypical Antipsychotics

Rentsch, K.

LC-MS(/MS) Analysis of Psychotropic Drugs

Rexelius, M.

Ziprasidone and Methyldihydroziprasidone Kinetics as Displayed in the Naturalistic Clinical Setting by Applying a TDM-Routine

Riedel, M.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Riederer, P.

Therapeutic Drug Monitoring in a Naturalistic Clinical Setting

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Rieger-Gies, A.

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

Rietschel, M.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Rimon, R.

Clozapine induced QEEG Changes Correlate with Clinical Response in Schizophrenic Patients – A Prospective, Longitudinal Study

Rochat, B.

Metabolism of Citalopram by MAO: Pharmacogenetic and Kinetic Animal Studies

Roeder-Aigner, J.

A First Report of Psychosis with Voriconazole in a Patient with AML and Bronchitis

Röschke, J.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Rosenqvist, U.

Therapeutic Drug Monitoring of Paroxetine in a Naturalistic Clinical Setting

Rothenhöfer, S.

Therapeutic Drug Monitoring of Quetiapine in Child and Adolescents

Rudberg, I.

Therapeutic Drug Monitoring in Psychiatry: Experience from Norway

Individual and Dose-Dependent Variability in R- and S-Mirtazapine Ratio Among Patients Treated with Racemic Mirtazapine

Ruether, E.

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Rujescu, D.

Genetic Polymorphisms and Antipsychotic Medication: Short Term and Long Term Effects

Rupp, M.

Relevance of Clinical Pharmacological Comments in TDM

Rüther, E.

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

AMSP Methods and Results on Severe ADR due to Antipsychotics

Plasma Prolactin Levels During Treatment with Olanzapine

Rygula, R.

Pharmacokinetic and Behavioural Effects of Antidepressants Given Orally via Drinking Water in Rats

Sachse, J.

Automated Analysis of Antipsychotic Drugs Using Liquid Chromatography with Column Switching

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Serum Concentrations of Quetiapine and Clinical Effects

Salvo, F.

Neuropsychiatric Adverse Drug Reactions in General Practice

Sandmann, U.

Haloperidol Pyridinium Serum Levels and Tardive Dyskinesia

Saria, A.

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

Schanz, B.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Scherer, A.

The German Network on Depression: TDM of New and Old Antidepressant Drugs

Schmidmeier, R.

Risperidone Plasma Levels in the Elderly with Dementia

Schmidt, L. G.

Weight Gain in the AMSP System

Schuhmann, T.

Sibutramin-induced Hypomania – A Case Report

Lewy Body Dementia, Pharmacotherapeutic Security and Differential Indication of Antipsychotics According to Adverse Effects – A Case Report

Schulz, P.

What Is the Evidence for Systematic Monitoring of Tricyclic Antidepressant Concentrations?

Nefazodone Withdrawal Syndrome Responds to the Administration of Trazodone

Schupp, U.

Therapeutic Drug Monitoring of Quetiapine in Child and Adolescents

Schwarz, M. J.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Scordo, M. G.

TDM and Pharmacogenetics in Relation to Side Effect Monitoring in Psychiatry

Sessa, A.

Neuropsychiatric Adverse Drug Reactions in General Practice

Shams, M.

Rapid and Reliable Genotyping Procedure for Detection of Alleles with Mutation, Deletion or/and Duplication of the CYP2D6-Gene

Sjöqvist, F.

TDM and Pharmacogenetics of Tricyclic Antidepressants – The Original Ideas

CYP2D6– a Key Enzyme in the Metabolism of Antidepressants and Neuroleptics

Spellmann, I.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Spigset, O.

Treatment of Women in Pregnancy and Lactation with Psychotropic Drugs

Spina, E.

TDM and Pharmacogenetics in Relation to Side Effect Monitoring in Psychiatry

Neuropsychiatric Adverse Drug Reactions in General Practice

Stephan, P.

TDM and Pharmacogenetic Tests as Tools in Pharmacovigilance: Case Reports

Stephan, P. L.

Severe Bruising as an Adverse Event: Chocolate or Fluvoxamine? Case Report

Strassnig, M.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Stroba, G.

Storage and Transport Stability of New Antidepressant and Antipsychotic Drugs

Stübner, S.

„Atypical Dyskinesia“ – Uncommon Adverse Reactions due to Psychotropic Drugs

Stuppäck, C.

Electrolyte Disturbances Due to Dual Antidepressants

Tadic, Andre

Genetic Polymorphisms and Antipsychotic Medication: Short Term and Long Term Effects

Tanum, L.

Therapeutic Drug Monitoring of Patients on Risperidone Depot

Individual and Dose-Dependent Variability in R- and S-Mirtazapine Ratio Among Patients Treated with Racemic Mirtazapine

Tauscher, J.

Brain Receptor Occupancy: A Measure for Pharmacological Activity?

Ufer, M.

Experience with CYP2D6 Genotyping in Psychiatry

Ulrich, S.

Pharmacovigilance of Jatrosom N (Tranylcypromine): Preliminary Data of a Post-Authorisation Surveillance Study

Haloperidol Pyridinium Serum Levels and Tardive Dyskinesia

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Unterecker, S.

Therapeutic Drug Monitoring in a Naturalistic Clinical Setting

Van der Velden, J. W.

The international Society for Pharmacoepidemiology

Current Issues and Legislation in Pharmacovigilance

Van Grootheest, K.

National Databases

von Widdern, O.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Wagner, M.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response

Waler, M.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Waschgler, R.

Preliminary Findings in Switching from Parenteral Haloperidol to Oral Quetiapine Treatment in the Management of Acutely Agitated Patients

Weber, K.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Wewetzer, C.

Therapeutic Drug Monitoring of Quetiapine in Child and Adolescents

Woggon, B.

High Dose Treatment of Patients Suffering from Mood Disorders

Zach, J.

Risperidone Plasma Levels, Clinical Response and Side-Effects

Zernig, G.

The Practice of TDM in an Austrian University Hospital Setting: What the Clinician Still has to be Reminded of ...

The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry

Zobel, A.

Genetic Analysis of Neurobiological Indicators of Antidepressant Drug Response